✦ LIBER ✦

758 CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO BY THE HCV NS3/4A PROTEASE INHIBITOR BI 201335

✍ Scribed by G. Kukolj; C. Bousquet; N. Dansereau; F. Dô; L. Lagacé; M. Llinàs-Brunet; M. Marquis; M.-J. Massariol; R. Maurice; C. Spickler; D. Thibeault; S. Zhao; P.W. White

Book ID: 117378842
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 51 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60760-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

777 PRECLINICAL CHARACTERIZATION OF NON-

777 PRECLINICAL CHARACTERIZATION OF NON-COVALENT HCV NS3/4A PROTEASE INHIBITOR BI 201335

✍ P.W. White; M. Llinas-Brunet; M. Amad; G. Bolger; M.G. Cordingley; J. Duan; M. G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

1236 MECHANISMS OF ISOLATED UNCONJUGATED

1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335

✍ Sane, R.; Podila, L.; Mathur, A.; Mease, K.; Taub, M.; Huang, Q.; Elgadi, M.; Ne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Potency, safety, and pharmacokinetics of

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

844 IN VITRO CHARACTERIZATION OF THE PAN

844 IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR

✍ J.A. Howe; D. Graham; P. McMonagle; S. Curry; R. Chase; F. Lahser; R.A. Ogert; J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Characterization of vaniprevir, a hepati

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB